Potential Neuropathic Pain Treatment Shows Promise in Preclinical Tests, Newsroom

A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study.

d-Amino acids: new clinical pathways for brain diseases: Trends in

Preclinical test indicates potential for treating neuropathic pain

Targeting nociceptive transient receptor potential channels to

Transient receptor potential channels in pulmonary chemical

Anesthesiology

Larry Schlossman

Delivering affordable cancer care in high-income countries - The

Potential Plausible Role of Stem Cell for Treating Depressive

Meds Pipeline Monitor 2021

Akelos

Full article: Neuropathic pain: preclinical and early clinical

Neuropathic pain: diagnosis, pathophysiological mechanisms, and